SCHEMBL4727870

SCHEMBL4727870

NC1CCN(c2cc(C3(C(F)F)Nc4ccccc4N3)nc(N3CCOCC3)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CB P42338 8/20 0.48
KMT2A Q03164 1/20 0.39
PIK3CA P42336 5/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MTOR P42345 1/20 0.38
MAP3K12 Q12852 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
PIK3CD O00329 2/20 0.37
TSHR P16473 1/20 0.37
ATR Q13535 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4726457 1.00 PIK3CB (0.48) PIK3CBKMT2APIK3CAKDM4EALDH1A1
SCHEMBL4728179 0.87 PIK3CA (0.43) PIK3CBPIK3CAMTORATR
SCHEMBL4727861 0.79 PIK3CA (0.37) PIK3CBPIK3CAMTORMAP3K12ATR
SCHEMBL4731075 0.77 HTT (0.49) KMT2APIK3CAKDM4EALDH1A1HSD17B10
SCHEMBL4794320 0.77 PIK3CA (0.48) PIK3CBPIK3CAKDM4EALDH1A1GLA
SCHEMBL4797718 0.77 PIK3CB (0.40) PIK3CBKMT2APIK3CAKDM4EALDH1A1
SCHEMBL4572916 0.75 PIK3CB (0.44) PIK3CBPIK3CAPIK3CD
SCHEMBL4574510 0.75 PIK3CB (0.44) PIK3CBPIK3CAPIK3CD
SCHEMBL4730678 0.75 PIK3CB (0.44) PIK3CBPIK3CAPIK3CD
SCHEMBL4730536 0.74 ATR (0.43) PIK3CBKMT2APIK3CAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008032036-A1 6-BENZIMIDAZ0LYL-2-M0RPH0LIN0-4- (AZETIDINE, PYRROLIDINE, PIPERIDINE OR AZEPINE) PYRIMIDINE DERIVATIVES AS PI3K AND MTOR INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-03-20 WO disclosed